Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease

Completed

Conditions: Smoking Cessation
Chronic Bronchitis
Smoking
Emphysema
Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date: 2009-09-10

Last Posted Date: 2020-07-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 171

Registration Number: NCT00974064

Locations: 🇺🇸
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York, New York, United States

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Phase 1

Completed

Conditions: Kidney Cancer
Gliomas
Head and Neck Cancer
Ovarian Cancer
Esophageal Cancer
Breast Cancer
Non-small Cell Lung Cancer
Colorectal Cancer
Pancreatic Cancer

Interventions: Drug: 177Lu-J591

First Posted Date: 2009-08-28

Last Posted Date: 2022-02-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT00967577

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors

Not Applicable

Completed

Conditions: Ischemic Stroke
Depression

Interventions: Behavioral: Ecosystem Focused Therapy (EFT)
Behavioral: Education in stroke and depression

First Posted Date: 2009-07-23

Last Posted Date: 2017-02-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 40

Registration Number: NCT00944762

Locations: 🇺🇸
The Burke Rehabilitation Hospital, White Plains, New York, United States

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Completed

Conditions: Hemophilia A
Hemophilia B

First Posted Date: 2009-07-10

Last Posted Date: 2012-12-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT00936312

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇩🇪
University Clinic Bonn, Bonn, Germany
🇮🇹
A. Bianchi Bonomi Hemophilia Center, Milan, Italy

and more 8 locations

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Completed

Conditions: Hemophilia A
Hemophilia B

First Posted Date: 2009-07-10

Last Posted Date: 2012-12-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 22

Registration Number: NCT00936845

Locations: 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸
Mountain States Regional Hemophilia and Thrombosis Center, Aurora, Colorado, United States
🇺🇸
Georgetown University Hospital, Washington, District of Columbia, United States

and more 16 locations

Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression

Completed

Conditions: Depression

Interventions: Drug: Escitalopram

First Posted Date: 2009-06-23

Last Posted Date: 2015-08-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 76

Registration Number: NCT00926653

Locations: 🇺🇸
New York Presbyterian-Weill Cornell Medical College, White Plains, New York, United States

Aging Brain Changes, Executive Dysfunction and Depression

Phase 4

Completed

Conditions: Depression

Interventions: Drug: Escitalopram

First Posted Date: 2009-06-11

Last Posted Date: 2017-05-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 116

Registration Number: NCT00918684

A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2

Terminated

Conditions: Diffuse Large B-cell Lymphoma

Interventions: Drug: dasatinib

First Posted Date: 2009-06-11

Last Posted Date: 2018-08-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 2

Registration Number: NCT00918463

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Melphalan
Drug: Bendamustine

First Posted Date: 2009-06-09

Last Posted Date: 2019-06-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 57

Registration Number: NCT00916058

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel
Drug: Prednisone
Drug: 177Lu-J591

First Posted Date: 2009-06-09

Last Posted Date: 2021-05-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT00916123

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of North Carolina Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy